AU5257198A - Compositions and methods for treating type ii diabetes involving hnf-4 - Google Patents

Compositions and methods for treating type ii diabetes involving hnf-4

Info

Publication number
AU5257198A
AU5257198A AU52571/98A AU5257198A AU5257198A AU 5257198 A AU5257198 A AU 5257198A AU 52571/98 A AU52571/98 A AU 52571/98A AU 5257198 A AU5257198 A AU 5257198A AU 5257198 A AU5257198 A AU 5257198A
Authority
AU
Australia
Prior art keywords
hnf
compositions
methods
treating type
diabetes involving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52571/98A
Other languages
English (en)
Inventor
Alexandra M. Glucksman
Jeffrey Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU5257198A publication Critical patent/AU5257198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU52571/98A 1996-11-15 1997-11-14 Compositions and methods for treating type ii diabetes involving hnf-4 Abandoned AU5257198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74943096A 1996-11-15 1996-11-15
US08749430 1996-11-15
PCT/US1997/020759 WO1998021363A1 (fr) 1996-11-15 1997-11-14 Compositions et therapies utilisables contre le diabete de type ii lie au hnf-4

Publications (1)

Publication Number Publication Date
AU5257198A true AU5257198A (en) 1998-06-03

Family

ID=25013733

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52571/98A Abandoned AU5257198A (en) 1996-11-15 1997-11-14 Compositions and methods for treating type ii diabetes involving hnf-4

Country Status (2)

Country Link
AU (1) AU5257198A (fr)
WO (1) WO1998021363A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187533B1 (en) 1996-09-10 2001-02-13 Arch Development Corporation Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (HNF) 1 alpha (α), HNF1β and HNF4α
CN1311200A (zh) * 2000-02-29 2001-09-05 复旦大学 一种新的多肽——人肝细胞核因子12和编码这种多肽的多核苷酸
WO2002072874A1 (fr) * 2001-03-14 2002-09-19 Fujisawa Pharmaceutical Co., Ltd. Procede de criblage d'un agoniste hnf4$g(a)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69131718T2 (de) * 1990-12-21 2000-03-02 Rockefeller University New Yor Aus leber angereicherter transkriptionsfaktor
FR2732978B1 (fr) * 1995-04-14 1997-05-30 Inst Nat Sante Rech Med Vecteur viral recombinant, composition pharmaceutique le contenant et cellules transformees correspondantes

Also Published As

Publication number Publication date
WO1998021363A1 (fr) 1998-05-22

Similar Documents

Publication Publication Date Title
AU8693098A (en) Compositions and methods for treating diabetes
AU1296099A (en) Methods and compositions for treating dermatoses
AU7275098A (en) Enhanced adenovirus-assisted transfection composition and method
AU5081298A (en) Surgical method and composition therefor
AU9214398A (en) Compositions and methods for treating water
AU9790198A (en) Compounds and methods
AU6111699A (en) Novel method and compounds
AU5819699A (en) Gaming apparatus and method
AU4012997A (en) Method and composition for incorporating radiation-absorbing agents into polymers
AU4261697A (en) Compounds and methods
AUPO976797A0 (en) Method and composition (III)
AU8019598A (en) Composition and method for providing glutamine
AU1705400A (en) Method and composition for treating and preventing tuberculosis
AUPO976597A0 (en) Method and composition (I)
AU9301998A (en) Composition and methods using galectin-1
AU4859399A (en) Compositions and methods for treating papillomavirus-infected cells
AU3200197A (en) New composition and methods
AUPN137895A0 (en) Composition and method
AU5257198A (en) Compositions and methods for treating type ii diabetes involving hnf-4
AU6966998A (en) Composition for treating pain
AUPO982097A0 (en) Methods and compositions for use therein
AU7247898A (en) Composition for treating pain
AU2461999A (en) Pharmaceutical composition and method for treating di-hydroxytestosterone dependent conditions
AU7604100A (en) Composition and method for treating burns
AU2586399A (en) Wound-healing composition and method